In the current analysis, we adopted the DEGs associated with necroptosis signatures, and constructed a KPNA2, SLC1A5 and RAMP3 model to evaluate the clinical features and prognosis in HCC, which provide key clues for acknowledging the role of necroptosis-related DEGs in HCC. The gene discussed is KPNA2; the disease is hepatocellular carcinoma.